Celularity CELU
NASDAQ CELU
$1.05 +0.03 (+2.94%)
At close: Oct 22, 2026 · 4:00 PM EDT

Celularity (CELU) Current Debt (2023 - 2026)

Updated

Analysis

Celularity (CELU) Current Debt (2023 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Debt (Qtr)
1 Eli Lilly 1,230.11 Bn 1,198.70 Bn 19.71 Bn 3.51 Bn
2 Johnson & Johnson 644.39 Bn 564.25 Bn 17.30 Bn -4.36 Bn
3 AbbVie 503.52 Bn 476.68 Bn 12.70 Bn -
4 Merck 363.29 Bn 317.72 Bn 12.21 Bn -
5 Novartis Ag 298.23 Bn 262.62 Bn 11.24 Bn 208.00 Mn
6 Astrazeneca 267.53 Bn 241.29 Bn 12.86 Bn -
7 Amgen 241.80 Bn 197.20 Bn 7.24 Bn -
8 Gilead Sciences 195.07 Bn 169.19 Bn 6.22 Bn -
9 Pfizer 173.33 Bn 120.28 Bn 10.94 Bn 64.00 Mn
10 Celularity 30.75 Mn 23.50 Mn 3.09 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 -7.04 Mn
Dec 31, 2025 -8,000.00
Sep 30, 2025 185,000.00
Jun 30, 2025 -256,000.00
Mar 31, 2025 -42,000.00
Dec 31, 2024 -40,000.00
Sep 30, 2024 -6,000.00
Jun 30, 2024 -90,000.00
Mar 31, 2024 -10,000.00
Jun 30, 2023 -15.19 Mn
Mar 31, 2023 -1.62 Mn
API Access

Celularity Current Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-debt&ticker=CELU&period=max&api_key=YOUR_API_KEY